FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/12/2025
Voltar para busca
Dado oficial do USPTO
DINATEQ
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
DINATEQ
ST13
US500000079386306Classe
5, 9, 10, 35, 42, 44
Pedido
79386306
Registro
7772611
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 35, 42, 44
Data de depósito
04/08/2023
Data de registro
29/04/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/04/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
JANSON, ANDREW KYLE
Unidade examinadora
L50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
DiNAQOR AG
Representantes
Alexander Montgomery Hinckley Allen & Snyder LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and substancesdrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; medicinal and biomedical preparations and substancesdrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; Biological tissue cultures for medical use; Biological solid organ tissue intended for subsequent implantation; Surgical implants made of living tissue; Biochemical preparations for medical use for the treatment of genetic diseases and cancersheart diseasesliver diseaseskidney diseasespancreas diseasesspleen diseaseslung diseases and cancer; Stem cells for medical use; pharmaceuticalmedicalbiomedical and veterinary preparationsin particular for the treatment of heart diseases
Classe 9
Recorded and downloadable computer software and platforms for data processingstorage and analysis for the development of gene therapies; recorded and downloadable computer software and computer software platforms for data processingstorage and analysis for use in medicalbiomedicalveterinary and pharmaceutical research and development; scientificresearchnavigationsurveyingphotographiccinematographicaudiovisualopticalmeasuringsignalingdetectiontestinginspectionteaching apparatus and instruments in the nature of high speed cameraselectric sensors and electric actuatorsoptical 2D scannersoptical filtersphotomultiplier tubes for use in medicalbiomedicalveterinary and pharmaceutical research and development; weighing apparatus and instruments for use in medicalbiomedicalveterinary and pharmaceutical research and development; Data processing equipment for use in medicalbiomedicalveterinary and pharmaceutical research and development
Classe 10
Medical apparatus and instruments for the treatment of genetic diseases and cancersheart diseasesliver diseaseskidney diseasespancreas diseasesspleen diseaseslung diseases; Surgical apparatus and instruments; Paramedical apparatus and instruments for the treatment of genetic diseases and cancersheart diseasesliver diseaseskidney diseasespancreas diseasesspleen diseaseslung diseases; Veterinary apparatus and instruments for the treatment of genetic diseases and cancersheart diseasesliver diseaseskidney diseasespancreas diseasesspleen diseaseslung diseases; Medical instruments for the fusion of medicinessyringesinfusion pumpssyringe systems comprising syringes and medical tubing for administering drugsintravenous mixing sets consisting of infusion bags sold emptymedical tubing for administering drugsclamps for securing medical tubingair filtersluer connectorsmedical laboratory mixersmedical vial reconstitution mixersnebulizersmedicine autoinjectors sold emptyballoon catheters; Apparatus for the regeneration of stem cells for medical purposes; Diagnostic apparatus for medical purposesfor medical diagnostic testing related to heart and kidney diseasesexcept vascular and cardiovascular implants and implanted apparatus; Infusion sets; Artificial biomaterials for the argumentation of cardiac and kidney tissue for medical purposes
Classe 35
Advertising services; Commercial business administrationorganization consultingmanagement; Providing office functions; Business management consultancy; Company communication servicespublic relations and providing business information for potential investors; Consulting services relating to personnel management; Personnel management; providing commercial information in the field of life sciencehealth technology and medical technology; Providing marketing information; drawing up of statements of accounts; Retail store and wholesale store services featuring chemical and medical products and preparationsmedical instruments and apparatussoftware in the medical field
Classe 42
Development and programming of computer software and software platforms for others for use in medicalbiomedicalveterinary and pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for data processingstorage and analysis for use in medicalbiomedicalveterinary and pharmaceutical research and development; Stem cell research services; Consulting services relating to medicalbiomedicalveterinary and pharmaceutical research and development; research and development services relating to medicalbiomedicalveterinary and pharmaceutical preparations; Providing information about medicalbiomedicalveterinary and pharmaceutical scientific research and development; Biological research and analysisanalysis of human tissue for medicalbiomedicalveterinary and pharmaceutical research purposes; design and development of medical diagnostic apparatus; Scientific research and development with respect to the isolation and cultivation of human cells and tissues; Programming of computer software for others for information platforms on the Internet for use in medicalbiomedicalveterinary and pharmaceutical research and development; Rental of laboratory apparatus and instruments for scientificresearchnavigationsurveyingphotographiccinematographicaudiovisualopticalweighingmeasuringsignalingdetectiontestinginspection and teaching purposes for use in medicalbiomedicalveterinary and pharmaceutical research and development; Rental of computer hardware and data processing equipment for use in medicalbiomedicalveterinary and pharmaceutical research and development
Classe 44
Providing medical information in the field of medical care as it relates to the preparation and dispensing medicationsin particular for cardiomyopathyheart failure and kidney diseases; Providing medical information and consulting services in the field of medical care as it relates to medicalbiomedicalveterinary and pharmaceutical products; Genetic screening for medicalbiomedicalveterinary and pharmaceutical purposes; Human heart and kidney tissue bank services; medical services relating to the removaltreatment and processing of stem cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/11/2025
FIMP
FINAL DISPOSITION PROCESSED
15/11/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/07/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
13/06/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/05/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/05/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
29/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/03/2025
PUBO
PUBLISHED FOR OPPOSITION
11/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/02/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
20/11/2024
GNFR
FINAL REFUSAL E-MAILED
20/11/2024
CNFR
FINAL REFUSAL WRITTEN
20/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/10/2024
RFNT
REFUSAL PROCESSED BY IB
22/05/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/04/2024
RFRR
REFUSAL PROCESSED BY MPU
27/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/04/2024
CNRT
NON-FINAL ACTION WRITTEN
09/04/2024
DOCK
ASSIGNED TO EXAMINER
05/04/2024
MAFR
APPLICATION FILING RECEIPT MAILED
02/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/12/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/12/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DINATEQ ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.